Novalgen_logo_on_white.jpg
NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
09. Januar 2023 07:00 ET | NovalGen Ltd.
LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- NovalGen Ltd (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies, alongside a disruptive auto-regulation platform, today...